APA

Schmidt C. J., Chapin D. S., Cianfrogna J., Corman M. L., Hajos M., Harms J. F., Hoffman W. E., Lebel L. A., McCarthy S. A., Nelson F. R., Proulx-LaFrance C., Majchrzak M. J., Ramirez A. D., Schmidt K., Seymour P. A., Siuciak J. A., Tingley F. D., Williams R. D., Verhoest P. R. & Menniti F. S. (20080519). Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. : The Journal of pharmacology and experimental therapeutics.

Chicago

Schmidt C J, Chapin D S, Cianfrogna J, Corman M L, Hajos M, Harms J F, Hoffman W E, Lebel L A, McCarthy S A, Nelson F R, Proulx-LaFrance C, Majchrzak M J, Ramirez A D, Schmidt K, Seymour P A, Siuciak J A, Tingley F D, Williams R D, Verhoest P R and Menniti F S. 20080519. Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. : The Journal of pharmacology and experimental therapeutics.

Harvard

Schmidt C. J., Chapin D. S., Cianfrogna J., Corman M. L., Hajos M., Harms J. F., Hoffman W. E., Lebel L. A., McCarthy S. A., Nelson F. R., Proulx-LaFrance C., Majchrzak M. J., Ramirez A. D., Schmidt K., Seymour P. A., Siuciak J. A., Tingley F. D., Williams R. D., Verhoest P. R. and Menniti F. S. (20080519). Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. : The Journal of pharmacology and experimental therapeutics.

MLA

Schmidt C J, Chapin D S, Cianfrogna J, Corman M L, Hajos M, Harms J F, Hoffman W E, Lebel L A, McCarthy S A, Nelson F R, Proulx-LaFrance C, Majchrzak M J, Ramirez A D, Schmidt K, Seymour P A, Siuciak J A, Tingley F D, Williams R D, Verhoest P R and Menniti F S. Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. : The Journal of pharmacology and experimental therapeutics. 20080519.